Meningitis Vaccine
Antibiotic exposure impedes pneumococcal meningitis vaccine protection
Published in Vaccine Weekly, August 24th, 2005
"The frequency of meningitis due to penicillin-resistant Streptococcus pneumoniae (PRP) has increased in recent years, making treatment failure more likely. It is currently expected that pneumococcal conjugate vaccines might curb this trend. We investigated this issue using a mathematical model applied to the current prevalence of resistance and antibiotic exposure in the United States and in France," researchers in France report.
"Our main finding was that the level of antibiotic exposure may limit the effect of the vaccine," said Laura Temime and collaborators at INSERM...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-24)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Oral spore vaccine based on attenuated B. anthracis developed - Breast Cancer Vaccine
Polyomavirus VP1/VP2Her2 virus-like particles prevent tumor growth - Lymphoma Vaccine
Tumor-derived idiotype vaccine for non-Hodgkin's lymphomas described - Malaria Vaccine
Plasmodium falciparum protein localizes to parasitophorous vacuole - Smallpox Vaccine
Bacteria act as delivery system for vaccines against bioterrorism agent - Allergy & Immunology
Agreement signed to commercialize epinephrine auto injector in Canada - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
